Hayward Holdings, Inc. — Form 8-K Summary
Business Context and Reporting Period
Hayward Holdings, Inc. filed this Current Report on Form 8-K on May 8, 2023, reporting entry into an underwriting agreement for a secondary offering of the company’s common stock. The filing does not report quarterly or annual operating results.
Material Transaction and Key Financial Details
- The offering covers 21,000,000 shares of common stock, including the underwriter’s 30-day option to purchase up to an additional 3,150,000 shares.
- All shares are being sold by existing stockholders; Hayward will not receive proceeds and will not purchase any shares.
- Goldman Sachs & Co. LLC is the underwriter and agreed to purchase the shares from the selling stockholders at $11.75 per share.
- The base offering has an implied gross transaction value of approximately $246.8 million, payable to the selling stockholders, excluding any exercise of the option and underwriting discounts or expenses.
- If the full option is exercised, the additional shares would represent approximately $37.0 million of gross transaction value at the stated price.
- The filing provides no new information on revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics.
Changes, Outlook, Risks, and Unusual Items
- The offering is a secondary sale and therefore does not directly increase Hayward’s cash, liquidity, or capitalization through new proceeds.
- Closing was expected on or about May 10, 2023, subject to customary closing conditions.
- The offering is being made pursuant to an effective automatic shelf registration statement filed with the SEC on May 2, 2022, and a prospectus supplement filed on May 8, 2023.
- The filing contains no management guidance, operating outlook, or new contingency disclosures.
- Investor considerations include the potential increase in publicly traded shares, selling-stockholder supply, and the underwriter’s option to purchase additional shares.
Most Important Facts to Verify
- Whether the offering closed as expected and the final number of shares sold.
- Whether Goldman Sachs exercised any portion of its 30-day option.
- The identities and remaining ownership positions of the selling stockholders.
- The final underwriting discounts, commissions, and offering expenses disclosed in the prospectus supplement.
- Any subsequent effect on Hayward’s public float, share price, and ownership concentration.